TANDEM DIABETES CARE INC

Tandem Diabetes Care designs, develops, and commercializes insulin delivery systems and related diabetes management technologies. The company's primary product is the t:slim X2 insulin pump, an automated insulin delivery system that administers insulin to people with diabetes. Tandem also manufactures the Tandem Mobi pump and produces consumable products including insulin cartridges and infusion sets required for pump operation. Beyond hardware, the company offers software and digital health solutions, including Tandem Source, a web-based data management platform that aggregates therapy data from insulin pumps and continuous glucose monitors, and Sugarmate, a mobile application for visualizing diabetes management information. The company maintains a research collaboration with the University of Virginia Center for Diabetes Technology focused on closed-loop insulin delivery systems.

Tandem operates primarily in the United States market with international presence. The company employs approximately 2,500 full-time employees and maintains headquarters in San Diego, California. Revenue is generated through sales of durable insulin pump devices, recurring sales of consumable cartridges and infusion sets, and software licensing arrangements. The consumable product category provides a recurring revenue stream as users require regular replacement supplies for ongoing diabetes management.